Viewing Study NCT01316250


Ignite Creation Date: 2025-12-24 @ 5:08 PM
Ignite Modification Date: 2025-12-29 @ 11:13 PM
Study NCT ID: NCT01316250
Status: COMPLETED
Last Update Posted: 2025-10-02
First Post: 2011-02-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Gleevec as Maintenance Therapy After Cytogenetic Response With Nilotinib in Newly Diagnosed Chronic Myelogenous Leukemia
Sponsor: American University of Beirut Medical Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module